SURG SurgePays, Inc.
Telephone Communications (No Radiotelephone) · Nasdaq · SEC CIK 1392694 · Fiscal year ends 12/31
Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-39.7%
TTM net income YoY-83.5%
TTM EPS YoY-80.5%
Revenue 3-yr CAGR-20.3%
Net income 3-yr CAGR—
Margins
Gross margin-38.6%
Operating margin-78.8%
Net margin-83.4%
FCF margin—
EBITDA margin-78.0%
Returns
ROE-313.7%
ROA-150.1%
ROIC (approx.)-232.0%
Asset turnover1.80x
Leverage & solvency
Liabilities / assets144.3%
Debt / equity—
Current ratio0.52x
Interest coverage-39.11x
Cash quality & payout
Operating cash flow / net income0.61x
Accruals ratio-58.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $56.96M | $60.88M |
| Cost of revenue | $67.55M | $75.21M |
| Gross profit | -$10.59M | -$14.32M |
| SG&A expense | $20.07M | $27.46M |
| Operating income | -$34.14M | -$43.46M |
| Interest expense | $2.00M | $554,200 |
| Pretax income | -$36.07M | -$43.07M |
| Income tax | — | $2.87M |
| Net income | -$36.07M | -$45.73M |
| EBITDA | -$33.93M | -$42.52M |
| EPS (basic) | -1.80 | -2.39 |
| EPS (diluted) | -1.80 | -2.39 |
| Weighted avg. shares (diluted) | 20.09M | 19.12M |
| Banking | ||
| Net interest income | $215,600 | — |
| Balance sheet | ||
| Cash & equivalents | $1.73M | $11.79M |
| Receivables | $4.05M | $3.00M |
| Inventory | $339,570 | $1.78M |
| Current assets | $6.98M | $17.87M |
| PP&E, net | $403,517 | $591,088 |
| Goodwill | — | $3.30M |
| Intangibles | $819,153 | $1.47M |
| Total assets | $8.52M | $23.98M |
| Current liabilities | $18.20M | $6.06M |
| Short-term debt | $16.96M | — |
| Long-term debt | $15.24M | $4.03M |
| Total debt | $32.20M | $4.03M |
| Total liabilities | $23.92M | $8.71M |
| Shareholders' equity | -$15.35M | $15.32M |
| Net debt | $30.47M | -$7.77M |
| Shares outstanding | 21.15M | 20.07M |
| Cash flow statement | ||
| Operating cash flow | -$21.29M | -$21.31M |
| Capital expenditure | $18,590 | $518,189 |
| Free cash flow | -$21.31M | -$21.83M |
| Investing cash flow | -$18,590 | -$3.00M |
| Financing cash flow | $10.53M | $22.48M |
| Depreciation & amortization | $206,161 | $942,450 |
| Stock-based compensation | $1.70M | $1.61M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.